(191 days)
Not Found
No
The summary describes a hyperbaric chamber and its physical features and operational parameters. There is no mention of AI or ML technology in the intended use, device description, or performance studies sections.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device is intended "to provide therapy to those patients with selected medical conditions that have been determined to respond to the application of hyperbaric oxygen."
No
The device is a hyperbaric oxygen treatment facility, intended for providing therapy to patients with certain medical conditions, not for diagnosing those conditions.
No
The device description clearly details a physical hyperbaric chamber with various hardware components (chamber, doors, control panel, oxygen delivery system, ventilation system, etc.), indicating it is a hardware device, not software-only.
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use clearly states that the device is used to provide therapy to patients with selected medical conditions by applying hyperbaric oxygen. This is a therapeutic intervention performed on a living patient, not a diagnostic test performed on a sample taken from a patient.
- Device Description: The device is described as a hyperbaric chamber designed to treat patients. It focuses on features related to patient comfort, safety, and the delivery of hyperbaric oxygen therapy. There is no mention of analyzing biological samples or performing diagnostic tests.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in samples
- Providing information for diagnosis, monitoring, or screening
- Using reagents or assays
The device is a therapeutic device used for hyperbaric oxygen therapy.
N/A
Intended Use / Indications for Use
It is the expressed, intended use of the Fink Engineering SL8/DL8 and TL20 Hyperbaric Oxygen Treatment Facilities to provide therapy to those patients with selected medical conditions that have been determined to respond to the application of hyperbaric oxygen. As a Class II prescriptive device, it is further intended for physician involvement in their procurement and routine use.
The UHMS is the professional medical organization chartered with setting the standards of care defining the appropriate use of hyperbaric oxygen. More specifically, the UHMS our cloning the appropriations that have been clearly established as appropriate primary or adjunctive use of hyperbaric oxygen (HBO). The disorders on the list have been primary of dajaridated and verified through extensive data collection. It should be noted that the list is dynamic. Based on the strength of the scientific data, disorders are both added and removed from the list, depending on the outcomes of scientific pursuit.
The conditions listed as appropriate for the use of HBO in the current edition of the Hyperbaric Oxygen Therapy Committee Report (1999) are as follows:
-
- Air or gas embolism
-
- Carbon monoxide poisoning and carbon monoxide poisoning complicated by cyanide poisoning
-
- Clostridial myositis and myonecrosis
-
- Crush injury, compartment syndrome, and other acute traumatic ischemias
-
- Decompression sickness
-
- Enhanced of selected problem wounds
-
- Exceptional blood loss anemia
-
- Necrotizing soft tissue infections
-
- Osteomyelitis (refractory)
-
- Delayed radiation injury (soft tissue and bony necrosis)
-
- Skin grafts and flaps (compromised)
-
- Thermal burns
-
- Intracranial abscess
Product codes (comma separated list FDA assigned to the subject device)
CBF
Device Description
The SL/DL8 and TL20 Hyperbaric Oxygen Treatment Facilities are Class A multiplace hyperbaric chambers designed to treat up to 8 (SL/DL8) or 20 (TL20) patient at up to a maximum operating pressure of 3 Atmospheres Absolute (ATA) or 29.4 pounds per square maximum operating procears of 0 %... 8 %... 6 %. or 73.5 psig for the DL8 and TL20. Each incil gauge (psig) for the OLD and up tessurization gas and 100% oxygen as the hyperbaric treatment gas.
The SL/DL8/TL20 rectangular hyperbaric chamber(s) include as a key component a new and very user-friendly rectangular chamber designed and manufactured specifically for the medical community to be used for hyperbaric oxygen treatment. The design of this unique ASME PVHO chamber has been driven by comments from hyperbaric physicians, technicians and nurses who require their equipment to be simple, easy to use and to simulate toomlount and harded inical conditions found elsewhere in their working environment.
The SL/DL8/TL20 facilities place major emphasis on patient comfort and user-friendly operator controls and incorporate several innovative and unique features including:
- A large, comfortable rectangular hyperbaric chamber that has been outfitted t . appear like any other clinical room in a hospital to reduce patient anxiety
- A rectangular medical lock with a unique locking system enabling single-handed . operation
- Large walk-trough rectangular sliding doors that fit flush with the floor so that . patients can be wheeled into the chamber without bumping over a door jam
- An easy to use control panel with large VDU display to monitor the treatment . profile including the internal chamber pressure, temperature, humidity, oxygen and carbon dioxide parameters
- An oxygen delivery system with venturi assisted overboard exhaust to eliminate . the possibility of "shrink wrapping" patients with their oxygen hoods
- Whisper quiet ventilation system to pneumatically control temperature, humidity . and upper oxygen limit without the need for internal electrical blowers
- Aesthetically pleasing external chamber cladding .
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
procured and used by pryololane to trout itst of medical conditions that have been identified for the appropriate primary or adjunctive use of hyperbaric oxygen. These approved conditions
physician involvement
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5470 Hyperbaric chamber.
(a)
Identification. A hyperbaric chamber is a device that is intended to increase the environmental oxygen pressure to promote the movement of oxygen from the environment to a patient's tissue by means of pressurization that is greater than atmospheric pressure. This device does not include topical oxygen chambers for extremities (§ 878.5650).(b)
Classification. Class II (performance standards).
0
K0316449
DEC - 5 2003
510(k) NOTIFICATION SUMMARY (Per 21 CFR 807.92)
Prepared: 26 May 2003
TRADE NAME: SL8 Hyperbaric Oxygen Treatment Facility DL8 Hyperbaric Oxygen Treatment Facility TL20 Hyperbaric Oxygen Treatment Facility
COMMON NAME OF DEVICE: Multiplace Hyperbaric Chamber
CLASSIFICATION: 73 CBF, 21 CFR 868.5470
ESTABLISHMENT REGISTRATION NUMBER: Pending
CLAIMED PREDICATE DEVICE(S):
Perry Sigma MP Multiplace Hyperbaric Chamber - K930748 Gulf Coast Multiplace Hyperbaric Chamber - K950957 Reimers T Class Hyperbaric Chamber - K954387
ADDRESS OF MANUFACTURER:
Fink Engineering PTY LTD 100 Talinga Road Cheltenham Victoria 3192 Australia Tele: 03-9585-2966
CONTACT PERSON: Eric Fink, Managing Director
EXECUTIVE SUMMARY
The Undersea and Hyperbaric Medical Society (UHMS) defines hyperbaric oxygen therapy The Ondersea and Hyperbart lessures higher than atmospheric in a hyperbaric chamber. as breating 100% offyger Fire Protection Association (NFPA), hyperbaric chambers are According to the National Fire Fress A (multi-occupant) and Class B (single occupant). The Classined into two outsgen Treatment Facilities are Class A multiplace hyperbaric chambers designed to treat up to 8 (SL/DL8) or 20 (TL20) patient at up to a maximum operating pressure of 3 Atmospheres Absolute (ATA) or 29.4 pounds per square maximum operating procears of 0 %... 8 %... 6 %. or 73.5 psig for the DL8 and TL20. Each incil gauge (psig) for the OLD and up tessurization gas and 100% oxygen as the hyperbaric treatment gas.
The SL/DL8 and TL20 Hyperbaric Oxygen Treatment Facilities are intended to be procured The UEDEO and TEE Fry tribate a variety of medical conditions that respond to hyperbaric and used by pryololane to trout itst of medical conditions that have been identified for the appropriate primary or adjunctive use of hyperbaric oxygen. These approved conditions
1
include: air or gas embolism; carbon monoxide poisoning and smoke inhalation; clostridial include. and of gas embolism, oalbert may and partment syndrome and other acute traumatic ischemias; decompression sickness; enhanced healing of selected problem wounds; lightinas, decompreasion visime rotizing soft tissue infections; osteomyelitis (refractory); radiation tissue damage (osteoradionecrosis); compromised skin flaps and grafts; thermal radiation though abscess. Aggressive research into the beneficial effects of burns, and, measure when appropriately applied, will result in additional medical conditions being added to the list of indications by the UHMS.
The SL/DL8 and TL20 Hyperbaric Oxygen Treatment Facilities are designed and fabricated in accordance with the requirements of the ANSI/ASME Boiler and Pressure Vessel Code, in abool admod will, Division 1, Pressure Vessels; ANSI/ASME-PVHO-1 (American Society of Scoton Vill, Engineers-Pressure Vessels for Human Occupancy); and, NFPA 99, Health Care Facilities, Chapter 19 (Chapter 20, 2002 Edition), Hyperbaric Facilities.
The SL/DL8/TL20 rectangular hyperbaric chamber(s) include as a key component a new and very user-friendly rectangular chamber designed and manufactured specifically for the medical community to be used for hyperbaric oxygen treatment. The design of this unique ASME PVHO chamber has been driven by comments from hyperbaric physicians, technicians and nurses who require their equipment to be simple, easy to use and to simulate toomlount and harded inical conditions found elsewhere in their working environment.
The SL/DL8/TL20 facilities place major emphasis on patient comfort and user-friendly operator controls and incorporate several innovative and unique features including:
- A large, comfortable rectangular hyperbaric chamber that has been outfitted t . appear like any other clinical room in a hospital to reduce patient anxiety
- A rectangular medical lock with a unique locking system enabling single-handed . operation
- Large walk-trough rectangular sliding doors that fit flush with the floor so that . patients can be wheeled into the chamber without bumping over a door jam
- An easy to use control panel with large VDU display to monitor the treatment . profile including the internal chamber pressure, temperature, humidity, oxygen and carbon dioxide parameters
- An oxygen delivery system with venturi assisted overboard exhaust to eliminate . the possibility of "shrink wrapping" patients with their oxygen hoods
- Whisper quiet ventilation system to pneumatically control temperature, humidity . and upper oxygen limit without the need for internal electrical blowers
- Aesthetically pleasing external chamber cladding .
Specifications of the SL8 Hyperbaric Oxygen Treatment Facility are as follows:
| Design Code | ASME Section VIII, Div 1 and ASME PVHO-1 |
|---|---|
| Operating Pressure | 3.0 ATA |
| Operating Temperature | 62°F to 100°F |
| Design Pressure | 32.3 psi |
| Design Temperature | 62°F to 100°F |
| Design Life | 70,000 cycles (30 years) |
| Hydrostatic Pressure | 42.0 psi |
| Inspection Authority | ASME "U" Stamp |
| Weight | ~15,432 lbs |
| Dimensions | 8.1ftW X 7ftH X 10.8 ft L |
| Volume | 586 ft³ |
| Medical Lock | 13.8 in X 13.8 in X 19.7 in |
| Doorway Size | 32.2 in X 75.6 in |
2
| Lighting
13 in ID viewports
5.9 in ID viewport
Capacity
Fire Suppression
Finish
Life Support Controls | Four external dimmable lights
Two PVHO
One PVHO
Eight seated persons
IAW NFPA 99
Shotblasted and Painted
Manual electropneumatic pressurization
Manual electropneumatic depressurization |
|------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Environmental Control
Ventilation
BIBS with overboard dump
Hoods with overboard dump
Depth Measurement
Gas Analysis
Communications | Heating
Constant airflow
Four
Four
Digital with analog backup
Oxygen and carbon dioxide
Internal/external PA System
Sound powered phone backup |
| Entertainment
TV System | Individual four-channel selection for eight persons
External color with remote control
AM/FM Tuner/CD & DVD Player |
Specifications of the DL8 Hyperbaric Oxygen Treatment Facility are as follows:
| Design Code | ASME Section VIII, Div 1 and ASME PVHO-1 |
|---|---|
| Operating Pressure | 6.0 ATA |
| Operating Temperature | 62°F to 100°F |
| Design Pressure | 80.0 psi |
| Design Temperature | 62°F to 100°F |
| Design Life | 70,000 cycles (30 years) |
| Hydrostatic Pressure | 104.0 psi |
| Inspection Authority | ASME "U" Stamp |
| Weight | ~26,400 lbs |
| Main Lock Dimensions | 8.1ftW X 7ftH X 11ftL |
| Entrance Lock Dimensions | 8.1ftW X 7ftH X 4.5ftL |
| Volume (ML) | 614.5 ft3 |
| Volume (EL) | 254.3 ft3 |
| Total Volume | 868.7 ft3 |
| Medical Lock | 13.8 in X 13.8 in X 19.7 in |
| Main Doorway Size | 39.4 in X 75.6 in |
| Lighting | Six external dimmable lights |
| 13.8 in ID viewports | Two PVHO in ML |
| 5.9 in ID viewports | One PVHO in each lock |
| Main Lock Capacity | Eight seated persons |
| Four wheelchairs | |
| One hospital gurney | |
| Fire Suppression | IAW NFPA 99 |
| Finish | Shotblasted and Painted |
| Life Support Controls | Manual electropneumatic pressurization |
| Manual electropneumatic depressurization | |
| Environmental Control | Heating |
| Ventilation | Constant airflow |
| BIBS with overboard dump | Two |
| Hoods with overboard dump | Six |
| Depth Measurement | Digital with analog backup |
| Gas Analysis | Oxygen and carbon dioxide |
| Communications | Internal/external PA System |
| Sound powered phone backup |
3
| Entertainment | Individual four-channel selection for eight persons |
|---|---|
| TV System | External color with remote control |
| Compartment Relief | AM/FM Tuner/CD & DVD Player |
| Compartment Drain | ASME certified relief valve |
| One manual drain valve in each lock |
Specifications of the TL20 Hyperbaric Oxygen Treatment Facility are as follows:
ASME Section VIII, Div 1 and ASME PVHO-1 Design Code Operating Pressure 6.0 ATA 62°F to 100°F Operating Temperature 80 psi Design Pressure 62°F to 100°F Design Temperature 70,000 cycles (30 years) Design Life 104.0 psi Hydrostatic Pressure ASME "U" Stamp Inspection Authority ~110,231 lbs Weight 10.3 ftW X 7ftH X 19.3 ftL Main Lock Dimensions 7.8 ftW X 7 ftH X 10.8ftL Entrance Lock Dimensions 7/8 ftW X 7 ftH X 10.8 ftL Inner Lock Dimensions 1536.2 ft3 Volume (ML) 529.7 ft3
480.3 ft3 Volume (EL) Volume (IL) 2546.2 H³ Total Volume 13.8 in X 13.8 in X 19.7 in Medical Lock 39.4 in X 75.6 in Main Doorway Size Fourteen external dimmable lights Lighting 23.6 in ID viewports Four PVHO Three PVHO 13 in ID viewports Two PVHO 6 in ID viewports Up to twenty persons Capacity Fire Suppression IAW NFPA 99 Shotblasted and Painted Finish Manual electropneumatic pressurization Life Support Controls Manual electropneumatic depressurization Environmental Control Heating Constant airflow Ventilation BIBS with overboard dump Four Twenty-two Hoods with overboard dump Digital with analog backup Depth Measurement Oxygen and carbon dioxide Gas Analysis Internal/external PA System Communications Sound powered phone backup Individual four-channel selection for eight persons Entertainment External color with remote control TV System AM/FM Tuner/CD & DVD Player
Fink Engineering has concluded that the general design approach, method of pressure control, and intended use of the SL&/DL8 and TL 20 Hyperbaric Oxygen Treatment Facilities are substantially equivalent to the Perry Baromedical Services Sigma MP Multiplace are ouberantially oque (KS30748), the Gulf Coast Multiplace Hyperbaric Chamber (K950957) and the Reimers Engineering T Class Multiplace Hyperbaric Chamber (K954387) and is proposing them as predicate devices for the SL8/DL8 and TL20 Hyperbaric Oxygen Treatment Facilities.
4
Intended Use:
It is the expressed, intended use of the Fink Engineering SL8/DL8 and TL20 Hyperbaric Oxygen Treatment Facilities to provide therapy to those patients with selected medical Oxygen Trouthons that have been determined to respond to the application of hyperbaric oxygen. As a Class II prescriptive device, it is further intended for physician involvement in their procurement and routine use.
The UHMS is the professional medical organization chartered with setting the standards of care defining the appropriate use of hyperbaric oxygen. More specifically, the UHMS our cloning the appropriations that have been clearly established as appropriate primary or adjunctive use of hyperbaric oxygen (HBO). The disorders on the list have been primary of dajaridated and verified through extensive data collection. It should be noted that the list is dynamic. Based on the strength of the scientific data, disorders are both added and removed from the list, depending on the outcomes of scientific pursuit.
The conditions listed as appropriate for the use of HBO in the current edition of the Hyperbaric Oxygen Therapy Committee Report (1999) are as follows:
- Air or gas embolism 1.
- Carbon monoxide poisoning and carbon monoxide poisoning complicated by 2. cvanide poisoning
- Clostridial myositis and myonecrosis ന്
- Crush injury, compartment syndrome, and other acute traumatic ischemias 4.
- Decompression sickness ട്.
- Enhanced of selected problem wounds .
- Exceptional blood loss anemia 7.
- Necrotizing soft tissue infections 8.
- Osteomyelitis (refractory) ഗ്
-
- Delayed radiation injury (soft tissue and bony necrosis)
-
- Skin grafts and flaps (compromised)
-
- Thermal burns
-
- Intracranial abscess
5
Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized graphic of an eagle or bird-like symbol with three curved lines representing its wings or body.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC - 5 2003
Fink Engineering Pty. Ltd. c/o Mr. W. T. Workman Workman Hyperbaric Services. Inc. 18111 Copper Ridge Dr. San Antonio, TX 78259
Re: K031649
Trade/Device Name: Multiplace Hyperbaric Oxygen Treatment Chamber, Models SL8/DL8/TL20 Regulation Number: 868.5470 Regulation Name: Hyperbaric Chamber Regulatory Class: II Product Code: CBF Dated: September 30, 2003 Received: October 1, 2003
Dear Mr. Workman:
. . . .
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
6
Page 2 - Mr. W. T. Workman
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Susan Runnd
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
7
Indications for Use
510(k) Number (if known): K031649
Device Name: Fink Engineering PTY LTD, SL8/DL8 and TL20 Hyperbaric Treatment Facilities
Indications For Use:
-
- Air or gas embolism
-
- Carbon monoxide poisoning and carbon monoxide poisoning complicated by cyanide poisoning
-
- Clostridial myositis and myonecrosis
-
- Crush injury, compartment syndrome, and other acute traumatic ischemias
-
- Decompression sickness
-
- Enhanced healing of selected problem wounds
-
- Exceptional anemia
-
- Necrotizing soft tissue infections
-
- Osteomyelitis (refractory)
-
- Delayed radiation injury (soft tissue and bony necrosis)
-
- Skin grafts and flaps (compromised)
-
- Thermal burns
-
- Intracranial abscess
X Prescription Use _ (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IN NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
- Intochu
Page 1 of
510(k) Number: K031649